Search research articles
Contact Us
Filters
Showing results (31-40 of 337) with videos related to
Page
of 34
Sort By:
Current Opinion in Molecular Therapeutics
|
July 22, 2004
Stable isotope-mass spectrometric measurements of molecular fluxes in vivo: emerging applications in drug development
Marc K Hellerstein, Elizabeth Murphy
Journal of Molecular and Cellular Cardiology
|
November 26, 2008
Why did the NHE inhibitor clinical trials fail?
Elizabeth Murphy, David G Allen
Journal of Molecular and Cellular Cardiology
|
October 10, 2006
How does endothelin-1 cause a sustained increase in intracellular sodium and calcium which lead to hypertrophy?
Elizabeth Murphy, David A Eisner
Circulation Research
|
January 17, 2020
Role of Mitochondrial Calcium and the Permeability Transition Pore in Regulating Cell Death
Tyler M Bauer, Elizabeth Murphy
Cardiovascular Research
|
August 20, 2022
Mitochondrial calcium and reactive oxygen species in cardiovascular disease
Elizabeth Murphy, Julia C Liu
Journal of Cardiovascular Pharmacology and Therapeutics
|
August 9, 2011
The role of comorbidities in cardioprotection
Michael N Sack, Elizabeth Murphy
Circulation Research
|
February 14, 2009
Regulation of intracellular and mitochondrial sodium in health and disease
Elizabeth Murphy, David A Eisner
American Journal of Physiology. Heart and Circulatory Physiology
|
September 1, 2009
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats
Anne M Deschamps, Elizabeth Murphy
Cardiovascular Research
|
May 22, 2021
Does the cardioprotective effect of Empagliflozin involve inhibition of the sodium-proton exchanger?
Elizabeth Murphy, David A Eisner
The Journal of General Physiology
|
December 19, 2024
How does mitochondrial Ca2+ change during ischemia and reperfusion? Implications for activation of the permeability transition pore
Elizabeth Murphy, David A Eisner
Page
of 34
Search research articles
Search
Showing results (31-40 of 337) with videos related to
Sort By:
Page
of 34
Current Opinion in Molecular Therapeutics
|
July 22, 2004
Stable isotope-mass spectrometric measurements of molecular fluxes in vivo: emerging applications in drug development
Marc K Hellerstein, Elizabeth Murphy
Journal of Molecular and Cellular Cardiology
|
November 26, 2008
Why did the NHE inhibitor clinical trials fail?
Elizabeth Murphy, David G Allen
Journal of Molecular and Cellular Cardiology
|
October 10, 2006
How does endothelin-1 cause a sustained increase in intracellular sodium and calcium which lead to hypertrophy?
Elizabeth Murphy, David A Eisner
Circulation Research
|
January 17, 2020
Role of Mitochondrial Calcium and the Permeability Transition Pore in Regulating Cell Death
Tyler M Bauer, Elizabeth Murphy
Cardiovascular Research
|
August 20, 2022
Mitochondrial calcium and reactive oxygen species in cardiovascular disease
Elizabeth Murphy, Julia C Liu
Journal of Cardiovascular Pharmacology and Therapeutics
|
August 9, 2011
The role of comorbidities in cardioprotection
Michael N Sack, Elizabeth Murphy
Circulation Research
|
February 14, 2009
Regulation of intracellular and mitochondrial sodium in health and disease
Elizabeth Murphy, David A Eisner
American Journal of Physiology. Heart and Circulatory Physiology
|
September 1, 2009
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats
Anne M Deschamps, Elizabeth Murphy
Cardiovascular Research
|
May 22, 2021
Does the cardioprotective effect of Empagliflozin involve inhibition of the sodium-proton exchanger?
Elizabeth Murphy, David A Eisner
The Journal of General Physiology
|
December 19, 2024
How does mitochondrial Ca2+ change during ischemia and reperfusion? Implications for activation of the permeability transition pore
Elizabeth Murphy, David A Eisner
Page
of 34